E. Hardin

471 total citations
17 papers, 116 citations indexed

About

E. Hardin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Hardin has authored 17 papers receiving a total of 116 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Hardin's work include Cardiovascular Function and Risk Factors (4 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Transplantation: Methods and Outcomes (3 papers). E. Hardin is often cited by papers focused on Cardiovascular Function and Risk Factors (4 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Transplantation: Methods and Outcomes (3 papers). E. Hardin collaborates with scholars based in United States, Australia and Canada. E. Hardin's co-authors include Kelly Chin, Justin L. Grodin, C. Jane Welsh, William D. King, Jay Pershad, Robin R. Johnson, Erin E. Young, Mary W. Meagher, Kathy Monroe and Elisabeth G. Vichaya and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and The American Journal of Medicine.

In The Last Decade

E. Hardin

12 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Hardin United States 6 55 23 23 15 13 17 116
Evelyn Santiago Spain 9 129 2.3× 27 1.2× 48 2.1× 4 0.3× 10 0.8× 12 176
Aurora Andrade Portugal 6 57 1.0× 15 0.7× 6 0.3× 5 0.3× 7 0.5× 25 112
Н. И. Волкова Russia 7 37 0.7× 27 1.2× 3 0.1× 5 0.3× 25 1.9× 66 169
Gianfranco Mazzotta Italy 8 102 1.9× 28 1.2× 5 0.2× 6 0.4× 2 0.2× 16 146
María Tamargo Spain 6 160 2.9× 33 1.4× 17 0.7× 2 0.1× 14 1.1× 14 180
Solange Bordignon Brazil 5 25 0.5× 16 0.7× 6 0.3× 6 0.4× 9 0.7× 11 85
Giuseppe Mancia Italy 5 91 1.7× 27 1.2× 5 0.2× 6 0.4× 14 1.1× 6 117
Lisanne C.C.J. Smans Netherlands 8 17 0.3× 43 1.9× 14 0.6× 44 2.9× 10 0.8× 10 354
Chuan Qin China 5 35 0.6× 13 0.6× 47 2.0× 3 0.2× 5 0.4× 17 87
Matthias Gruendling Germany 3 10 0.2× 9 0.4× 6 0.3× 14 0.9× 29 2.2× 5 79

Countries citing papers authored by E. Hardin

Since Specialization
Citations

This map shows the geographic impact of E. Hardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Hardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Hardin more than expected).

Fields of papers citing papers by E. Hardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Hardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Hardin. The network helps show where E. Hardin may publish in the future.

Co-authorship network of co-authors of E. Hardin

This figure shows the co-authorship network connecting the top 25 collaborators of E. Hardin. A scholar is included among the top collaborators of E. Hardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Hardin. E. Hardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dowell, Jonathan E., Nicholas Hendren, E. Hardin, et al.. (2025). Primary Graft Dysfunction after Heart Transplantation: Current Evidence and Implications for Clinical Practice. Current Cardiology Reports. 27(1). 24–24.
2.
Edwards, M. J., Melanie B. Thomas, L. Truby, et al.. (2024). Glucagon-Like Peptide-1 Agonist Use for Obesity Treatment in Patients with Left Ventricular Assist Devices. The Journal of Heart and Lung Transplantation. 43(4). S23–S23.
3.
Farr, Maryjane, Patrick J. O’Hara, Nicholas Hendren, et al.. (2024). Novel therapeutic agents for cardiometabolic risk mitigation in heart transplant recipients. The Journal of Heart and Lung Transplantation. 44(4). 477–486.
4.
Shah, Trushil, et al.. (2023). Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy. Pulmonary Circulation. 13(2). e12226–e12226. 3 indexed citations
5.
Shah, Trushil, et al.. (2022). Prognostic Value of Echocardiographic Variables Prior to and Following Initiation of Parenteral Prostacyclin Therapy. CHEST Journal. 162(3). 669–683. 3 indexed citations
6.
Drazner, Mark H., Colby Ayers, Justin L. Grodin, et al.. (2021). Identifying Discordance of Right- and Left-Ventricular Filling Pressures in Patients With Heart Failure by the Clinical Examination. Circulation Heart Failure. 14(11). e008779–e008779. 9 indexed citations
7.
Hardin, E., et al.. (2021). Markers of Immune Function in Heart Transplantation: Implications for Immunosuppression and Screening for Rejection. Current Heart Failure Reports. 18(2). 33–40. 3 indexed citations
8.
Amin, Alpesh, et al.. (2020). Small Vein Pulsations: An Overlooked Sign of Poor Prognosis. The American Journal of Medicine. 133(10). e597–e598.
9.
Hardin, E., Douglas Stoller, Justin S. Lawley, et al.. (2020). Noninvasive Assessment of Cardiac Output: Accuracy and Precision of the Closed‐Circuit Acetylene Rebreathing Technique for Cardiac Output Measurement. Journal of the American Heart Association. 9(17). e015794–e015794. 22 indexed citations
10.
Hardin, E. & Justin L. Grodin. (2017). Diuretic Strategies in Acute Decompensated Heart Failure. Current Heart Failure Reports. 14(2). 127–133. 13 indexed citations
11.
Hardin, E. & Kelly Chin. (2016). Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy. Drug Design Development and Therapy. Volume 10. 3747–3754. 15 indexed citations
12.
Hardin, E. & Bryon Adinoff. (2008). Family History of Alcoholism Does Not Influence Adrenocortical Hyporesponsiveness in Abstinent Alcohol-Dependent Men. The American Journal of Drug and Alcohol Abuse. 34(2). 151–160. 2 indexed citations
13.
Meagher, Mary W., Robin R. Johnson, Erin E. Young, et al.. (2007). Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler’s virus infection. Brain Behavior and Immunity. 21(8). 1083–1095. 27 indexed citations
14.
Hardin, E., Anne C. Pavlick, Leonard Liebes, et al.. (2006). A phase II trial of BAY 43–9006 in metastatic melanoma with molecularly characterized B-Raf status. Journal of Clinical Oncology. 24(18_suppl). 8046–8046. 2 indexed citations
15.
Pershad, Jay, et al.. (2000). Can Clinical Parameters Predict Fractures in Acute Pediatric Wrist Injuries?. Academic Emergency Medicine. 7(10). 1152–1155. 15 indexed citations
16.
Shoemaker, William C., Paul L. Appel, Mike Bishop, & E. Hardin. (1994). TEMPORAL BLOOD VOLUME, HEMODYNAMIC AND OXYGEN TRANSPORT PATTERNS IN ARDS. Critical Care Medicine. 22(1). A86–A86. 2 indexed citations
17.
Hardin, E., et al.. (1973). The Principal and School Law. NASSP Bulletin. 57(376). 48–54.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026